Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Nodality and Pfizer enter multiyear strategic collaboration

Aug. 10, 2012

Galenea and CHDI Foundation extend and expand Huntington's disease collaboration

Aug. 10, 2012

Salix and Alfa Wassermann enter agreement for EIR rifaximin formulation

Aug. 10, 2012

Actinium and Philogen partner to develop adhesion-targeted anticancer radiotherapies

Aug. 10, 2012

Synthetic Biologics to use Intrexon technology for mAb development

Aug. 10, 2012

MEI Pharma enters agreement to acquire rights to oral HDAC inhibitor

Aug. 9, 2012

AstraZeneca to halt development of CytoFab

Aug. 8, 2012

Mylan out-licenses Japanese rights to next-generation epinephrine product

Aug. 8, 2012

Foundation Medicine and Clovis Oncology launch collaboration

Aug. 8, 2012

Saladax and Bristol-Myers Squibb expand collaboration

Aug. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...